Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Drug alerts - COX-2

About the author: 

Another anti-inflammatory bites the dustAnother COX-2 inhibitor has been shot down by the FDA

Another anti-inflammatory bites the dustAnother COX-2 inhibitor has been shot down by the FDA. Having spent the last two months reviewing the safety of the COX-2-selective non-steroidal anti-inflammatory drugs (NSAIDs), the US regulatory agency has decided that the risks of life-threatening side-effects associated with Pfizer's Bextra outweigh its benefits.

As a result, the pharmaceutical giant has been 'requested' to voluntarily suspend all sales and marketing of the drug. According to the FDA, its decision was swayed by the lack of adequate data confirming cardiovascular safety with long-term use of Bextra, along with the increased risk of adverse cardiovascular events, reports of serious and potentially life-threatening skin reactions - including deaths - and the lack of any demonstrated advantages with Bextra compared with other NSAIDs.

In addition, manufacturers of all marketed prescription NSAIDs, including the other COX-2 drug, Celebrex, will have to revise the labelling for their products to include a warning to healthcare professionals and consumers of the increased risk of cardiovascular events and of potentially fatal gastrointestinal bleeding associated with these drugs. Even over-the-counter NSAIDs, such as ibuprofen, have been sent to the doghouse, with manufacturers being asked to include more specific information as to the potential risks.

The only drug let off the hook is aspirin because "it has clearly been shown to reduce the risk of serious adverse cardiovascular events in certain patient populations", says the FDA.


So you think you need . . . a colostomy

You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved